Upcoming Events
January 8 - January 10, 2025
January 15, 2025 at 9:00 AM PST
Patrick Amstutz
Chief Executive Officer
March 7, 2025
April 16, 2025
Past Events
October 31, 2024
August 27, 2024 at 8:00 AM EDT
June 17, 2024 at 10:40 AM EDT
April 17, 2024
March 15, 2024 at 8:00 AM EDT
March 11 - March 13, 2024
Fontainebleau Miami Beach
March 6, 2024 at 10:30 AM EST
Boston, MA
March 5, 2024 from 9:10 AM to 10:10 AM EST
January 10, 2024 at 10:30 AM PST
San Francisco, CA
January 10, 2024 at 10:30 AM EST
Bad Ragaz, Switzerland
November 15, 2023 at 8:00 AM EST
November 3, 2023 at 9:00 AM EDT
August 25, 2023 at 8:00 AM EDT
H1 2023 Results Presentation 2.9 MB
June 20, 2023 at 12:00 PM EDT
May 17, 2023 at 2:05 PM EDT
April 4, 2023
March 10, 2023 at 8:00 AM EST
March 8, 2023 at 9:10 AM EST
February 28 - March 1, 2023
February 15, 2023 at 12:00 PM EST
January 13, 2023
January 12, 2023 at 10:00 AM EST
January 11, 2023 at 10:30 AM EST
San Francisco, CA
Patrick Amstutz, Ph.D.
Chief Executive Officer
December 10, 2022 from 7:30 PM to 9:30 PM CST
November 29, 2022 at 8:00 AM EST
November 15, 2022
November 10, 2022
Poster: “A phase 1 study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin, in patients with relapsed/refractory solid tumors”
Number: 1475
October 27, 2022
August 26, 2022 at 8:00 AM EDT
August 25, 2022
(After Market Close)
May 17, 2022 at 9:00 AM EDT
InterContinental New York Barclay Hotel
New York, NY
April 20, 2022 at 10:30 AM EDT
April 13, 2022 at 2:00 PM CEST
Registered Office of Molecular Partners AG
Wagistrasse 14,
8952 Schlieren,
Switzerland.
8952 Schlieren,
Switzerland.
March 16, 2022 at 8:00 AM EDT
Switzerland / Europe | +41 800 836 507 |
USA | +1 844 865 3856 |
Conference ID | 5295679 |
March 15, 2022
March 9, 2022 at 2:40 PM EST
March 1 - March 2, 2022
February 16, 2022 at 9:20 AM EST
January 14, 2022
January 12, 2022 at 10:30 AM EST
January 12, 2022 at 7:30 AM EST
January 10, 2022 at 12:00 PM EST
January 10, 2022 at 7:00 AM EST
To register for the conference call, please dial the following numbers approximately 10 minutes before the start of the presentation:
Switzerland / Europe | 0800836508 |
USA | (844) 865-3856 |
Conference ID | 5090778 |
December 15, 2021 at 8:30 AM EST
December 11 - December 14, 2021
December 6, 2021
November 30, 2021 at 8:00 AM EST
October 28, 2021
October 28, 2021
October 20, 2021
September 13, 2021 at 7:00 AM EDT
September 10, 2021 at 11:00 AM EDT
August 26, 2021
Participant Dial in Number
US/CANADA Participant Toll-Free Dial-In Number: (844) 865-3856
US/CANADA Participant International Dial-In Number: (612) 979-9905
Conference ID: 9774461
Switzerland 0800836508
Switzerland, Geneva 0225803283
Switzerland, Zurich 0445801733
Conference ID 9774461
Half Year Report 2021 5.5 MB
May 18, 2021
March 9, 2021
March 2, 2021
February 25, 2021
February 5, 2021 at 2:00 PM CET
January 14, 2021
January 13, 2021
January 11, 2021
December 17, 2020
R&D Day 2020 (Virtual) 4.7 MB
December 1, 2020
November 9, 2020
MP Corporate Presentation 3.5 MB
October 28, 2020
September 16, 2020
September 14, 2020
August 26, 2020
June 26, 2020
March 3, 2020
February 26, 2020
February 6, 2020 at 2:00 PM CET
Molecular Partners HQ, Schlieren
January 16, 2020
December 12, 2019
R&D Day 2019 12.4 MB
December 4, 2019
August 27, 2019
March 12, 2019
February 7, 2019 at 2:00 PM CET
Location: Molecular Partners HQ, Schlieren
January 9, 2019
January 9, 2019
December 19, 2018
December 6, 2018
R&D Day 2018 6.9 MB
December 6, 2018
Corporate Factsheet 1.7 MB
November 1, 2018
September 12, 2018
August 30, 2018
July 19, 2018
March 13, 2018
February 8, 2018 at 2:00 PM CET
Location: Molecular Partners HQ, Schlieren
January 10, 2018
November 9, 2017
R&D Update in New York 8.3 MB
September 12, 2017
August 30, 2017
March 7, 2017
February 9, 2017 at 2:00 PM CET
January 11, 2017